- Home
- NBY vs NDRA Comparison
NBY vs NDRA Comparison
Compare NBY & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- NDRA
- Stock Information
- Founded
- NBY 2000
- NDRA 2007
- Country
- NBY United States
- NDRA United States
- Employees
- NBY N/A
- NDRA N/A
- Industry
- NBY
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NBY
- NDRA Health Care
- Exchange
- NBY Nasdaq
- NDRA Nasdaq
- Market Cap
- NBY 6.3M
- NDRA 7.3M
- IPO Year
- NBY 2007
- NDRA 2017
- Fundamental
- Price
- NBY $1.09
- NDRA $6.30
- Analyst Decision
- NBY
- NDRA Strong Buy
- Analyst Count
- NBY 0
- NDRA 1
- Target Price
- NBY N/A
- NDRA $38.00
- AVG Volume (30 Days)
- NBY 318.2K
- NDRA 91.5K
- Earning Date
- NBY 11-07-2025
- NDRA 11-14-2025
- Dividend Yield
- NBY N/A
- NDRA N/A
- EPS Growth
- NBY N/A
- NDRA N/A
- EPS
- NBY 0.52
- NDRA N/A
- Revenue
- NBY $7,861,000.00
- NDRA N/A
- Revenue This Year
- NBY $23.91
- NDRA N/A
- Revenue Next Year
- NBY $32.05
- NDRA N/A
- P/E Ratio
- NBY $1.96
- NDRA N/A
- Revenue Growth
- NBY 73.07
- NDRA N/A
- 52 Week Low
- NBY $0.46
- NDRA $2.90
- 52 Week High
- NBY $4.44
- NDRA $11.96
- Technical
- Relative Strength Index (RSI)
- NBY 43.58
- NDRA 58.16
- Support Level
- NBY $0.98
- NDRA $4.99
- Resistance Level
- NBY $1.09
- NDRA $5.99
- Average True Range (ATR)
- NBY 0.07
- NDRA 0.52
- MACD
- NBY 0.01
- NDRA 0.05
- Stochastic Oscillator
- NBY 30.31
- NDRA 70.33
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.